Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Secretor status-dependent modulation of in vitro immune responses by human milk oligosaccharides.

Created on 10 Jul 2026

Authors

Marit Zuurveld, Anneke Hellinga, Kennedy Spann, Lars Bode, Belinda Van't Land, Johan Garssen

Published in

Frontiers in nutrition. Volume 13. Pages 1791158. Epub Jun 12, 2026.

Abstract

Human milk oligosaccharides (HMOs) are structurally diverse carbohydrates found in high concentrations in human milk, supporting infant immune development and gut microbiota colonization. Their composition is influenced by maternal Secretor (Se) status, determined by the FUT2 gene. While immunological HMO effects are increasingly recognized, the influence of an infant's own Se status on immune responses remains understudied. This study explores how peripheral blood mononuclear cells (PBMCs) from Se-positive (Se+) and Se-negative (Se-) individuals respond to Se+ and Se- HMOs under bacterial and viral stimulation.
PBMCs from 14 healthy adult donors, classified based on FUT2 expression, were exposed to 0.1% pooled Se+ or Se- HMOs, individual HMOs (2'-fucosyllactose and 3-fucosyllactose), and immune triggers (αCD3/CD28, LPS, and/or Poly I:C) for 24-48 h. Cytokine secretion (IFNγ, IL10, IL13, TNFα) was measured.
Basal cytokine secretion did not differ between Se+ and Se- PBMCs. Upon stimulation, Se+ PBMCs secreted more IL10, particularly in response to Se+ or Se- HMOs. Individual HMOs did not replicate effects seen with pooled mixtures, highlighting the importance of HMO complexity. Under LPS stimulation, TNFα secretion was significantly reduced only with genotype-matched HMOs, suggesting Secretor-specific immune modulation.
This is the first study showing that PBMC cytokine responses are shaped mainly by host Secretor status than HMO composition. Both genotype and HMO profile influence immune reactivity and should be considered in HMO research and personalized infant nutrition strategies.

PMID:
42428615
Bibliographic data and abstract were imported from PubMed on 10 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement